1.Renoprotective effect of reduced glutathione in diabetic rats and its mechanism
Journal of Jilin University(Medicine Edition) 2006;0(02):-
Objective To investigate the renoprotective effect of reduced glutathione on streptozotocin-induced diabetic rats and its possible mechanism.Methods Streptozotocin-induced diabetic rats received aminoguanidine(50 mg?kg~(-1)?d~(-1)) and reduced glutathione 400 mg?kg~(-1)?d~(-1) intraperitoneally respectively or synchronously for(8 weeks.) The expression of TGF-?1 mRNA and protein in renal cortex were determined by reverse transcription polymerase chain reaction(RT-PCR) and immunohistochemistry respectively.The mean glomerular area(MGA) and volume(MGV) were measured by image analysis system.The changes of creatinine clearance rate(Ccr),the kidney weight/body weight ratio and the urinary albumin excretion rate(UAER) were determined.Results By the end of 8 weeks,the Ccr,UAER,MGA,MGV,kidney weight/body weight ratio,the contents of TGF-?1 mRNA in renal cortex were increased significantly in DM groups compared with the blank control group(P
2.Clinical Analysis of Coronary Heart Disease Combined with Diabetes
Chinese Journal of Primary Medicine and Pharmacy 2009;16(11):1948-1949
Objective To explore the clinical correlation of coronary heart disease with diabetes.Method From January 2005 to December 2008,268 patients were enrolled and randomly divided into the study group(Coronary Heart Disease combined with Diabetes)and the control group(Coronary Heart Disease).Blood pressure,hyperlipemia,degree of vasculopathy and chief heart incident was compared.Result The rate of blood pressure,hyperlipemia and chief heart incident in the control group were significantly lower than the study group(P<0.05).The incidence rates of multi-branches lesions in the control group were significantly lower than the study group(P<0.05).The incidence rates of single-branches lesions in the study group were significantly lower than the control group(P<0.05).Conclusion Active measures should be taken to prevent diabetes and control the risk factors like blood sugar,blood fat,blood pressure,weight and so on in order to prevent the attack of coronary artery diseases.
3.The neuroprotective effect of hypoxia-inducible factor-1 and vascular endothelial growth factor in cerebral ischemia
International Journal of Cerebrovascular Diseases 2011;19(2):142-146
Hypoxia-inducible factor(HIF)is a pivotal transcription factor for hypoxic response.This article reviews the related characteristics of HIF-1 and its target genes vascular endothelial growth factor and the neuroprotective mechanisrms in cerebral ischemia.
4.Transcatheter lipiodol chemoembolization of the inferior phrenic artery in hepatocellular carcinoma
Fanghong CHEN ; Zuyan LUO ; Jianhua YUAN
Journal of Interventional Radiology 1994;0(04):-
Objective To evaluate the efficacy of transcatheter lipiodol chemoembolization therapy (TOCE) for HCC via inferior phrenic artery (IPA) and to analyse the location of the tumor feeding inferior phrenic artey. Methods Twenty five cases of HCC underwent the procedure of TOCE via the IPA, as well as the hepatic artery using Seldinger's method. The patterns of tumor growth included huge type in 12 cases, solitary nodular type in 8 cases and multiple nodular type in 5 cases. Hepatic artery and inferior phrenic artery chemoembolizations were performed in all cases. Results Inferior phrenic artery originated from celiac trunk in 16 cases (64%); abdomen aorta around celiac trunck in 8(32%). The sitesot tumors supplied by IPA in right lobe (Ⅶ,Ⅷ segment) were 23 cases and left lobe (Ⅳ segment) 2 cases. The cumulative survival rates of IPA chemoembolization for hepatocellular carcinoma were 84%(1 year) and 68%(2 years). No severe complications occurred. Conclusions TOCE of the IPA is a safe and effective method in the management of HCC supplied by IPA. When the tumor site is adjacent to diaphragm, hepatic ligaments or bare area, may arouse the blood supply by IPA, especially in no tumor staining or staining defect in hepatic artery angiography but tumor enhancement on CT, and increase of the level of serum ? fetoprotein.
5.Preparation and application of the tumescent solution in the ultrosonic liposuction
Shengkang LUO ; Zhiqi HU ; Jianhua GAO
Chinese Journal of Medical Aesthetics and Cosmetology 2001;0(05):-
Objective To explore the application and formulas of the tumescent technique in the ultrosonic liposuction for better and more predictable reseults. Methods The tumescent technique formulas were present and analysed through 318 cases of ultrosonic liposuction. Results The following regimen was recommended as a result of the above studies: Lactated Ringer's solution or nosmal sodium was the fluid of choice; Lidocaine (500 mg/l) was a reference anesthetic. The maximal safe dose recommended for liposuction was 35 mg/kg body weight and total dose of epinephrine was 2~3 mg/l. But its concentation should be lower than 1:1 000 000. Concentration of sodium bicarbonate was 500 mg/l, and higer doses were of no value but harmless. Conclusions Safer formulas are provided for the tumescent technique administration in the ultrosonic liposuction. The tumescent technique may reduce potential complications related to ultrosonic liposuction
6.Comparative study of external ultrasonic tumescent liposuction and traditional tumescent liposuction
Min LI ; Jianhua GAO ; Shengkang LUO
Chinese Journal of Medical Aesthetics and Cosmetology 2001;0(04):-
Objective To discuss the benefits of the external ultrasonic liposuction through comparing the different effects of external ultrasonic tumescent liposuction and simple negative pressure liposuction. Methods The clinical effects of ten patients were compared, in which one side of abdomen was treated with external ultrasonic tumescent liposuction, and the other side with tumescent liposuction and the aspirates were analyzed. Results The percentage of supernatant fat in the whole aspirated volume on the ultrasonic treated sides was higher than that of non ultrasonic treated sides ( P
7.The clinical application of domestic biliary metallic stents
Zuyan LUO ; Fanghong CHEN ; Jianhua YUAN
Journal of Interventional Radiology 2001;0(05):-
Objective To determine the clinical efficacy and safety of domestic biliary metallic stents in the management of biliary obstruction. Methods 75 domestic biliary metallic stents were implanted in 66 of 72 patients with obstructive jaundice due to malignant (n=70) and benign stenoses (n=2). Results The technical successful rate was 92.7% (64/66). Palliation with rid of jaundice was achieved in 96.9% (64/66) within 1 month. The 30-day mortality rate was 3% (2/66). Early complications occurred in 7.6% (5/66). 44 patients were followed from 2 to 24 months after treatment. 33 (33/42) of 42 patients with malignancy died after a median survival of 5.3 months (range 2-23 months). The remaining 9 patients (9/42) remained alive with a mean follow-up of 11.6 months. The stent patency rates were 92.8%,89.9% and 79.4% at 3,6,12 months respectively. 6 patients (6/42) presented stent occlusion within a median period of 3 months. One of two patients with benign stenoses sustained a patency duration time of 24 months. One patient died 3 months after treatment. Conclusions The domestic biliary metallic stent implantation is efficacy and safety in the management of biliary obstruction.
8.Mid-term effect of direct intrahepatic portosystemic shunt for the treatment of portal hypertension
Jianjun LUO ; Zhiping YAN ; Jianhua WANG ; Qingxin LIU ; Xudong QU
Journal of Interventional Radiology 2006;0(08):-
Objective To retrospectively analyze the mid-term clinical results of direct intrahepatic portosystemic shunt (DIPS) in treating patients with portal hypertension. Methods DIPS were created in 23 patients with portal hypertension. Both preoperative and postoperative portal systemic pressure gradient (PPG), liver function and clinical symptoms were recorded and compared. Shunt patency was checked by color Doppler ultrasonography and the data were statistically analyzed by Kaplan-Meier method. Results DIPS creation was successfully accomplished in all 23 patients. No serious complications occurred after DIPS except for hemorrhagic ascites (n = 1) and mild hepatic encephalopathy (n = 3). Mean PPG significantly decreased from preoperative (32.6 ? 5.3) mmHg with a range of (23 - 43) mmHg to postoperative (10.1 ? 2.7) mmHg with a range of (5-14) mmHg (P
9.Implantation of radioactive ~(125)I seed strand and metallic stent combined with TACE for the treatment of HCC with IVC obstruction:initial results in 8 patients
Jianjun LUO ; Zhiping YAN ; Jianhua WANG ; Qingxin LIU ; Xudong QU
Journal of Interventional Radiology 2006;0(11):-
Objective To report the preliminary results of placing metallic stent and 125I seed strand combined with transcatheter arterial chemoembolization(TACE) for the treatment of hepatocellular carcinoma(HCC) with inferior vena cava(IVC) obstruction.Methods From March 2009 to June 2009,implantation of radioactive 125I seed strand and metallic stent combined with TACE treatment was performed in 8 cases of HCC with malignant IVC obstruction.All patients were males with a mean age of(60.6 ? 9.6) years.125I seed strand and Z-type self-expandable metallic stent were placed in the obstructive segment of IVC,which was followed by TACE.Before and after the treatment,the diameter of the obstructive segment of IVC,the pressure gradient between right atrium and distal end of obstructive segment of IVC,and the symptoms related to the obstruction were estimated and recorded,the results were compared individually.Clinical follow-up was conducted in all patients.Results A total of 8 stents and 10 125I seed strands were placed in the obstructive segment of IVC.Altogether 138 125I seeds were implanted in 8 patients.Obvious clinical improvements were obtained after therapy.No complications occurred in all patients except one patient who experienced acute renal dysfunction at the second day after therapy.During a mean of(2.1 ? 0.6) months follow-up,occlusion of IVC stent was detected in 1 patient.The remaining stents remained patent.Conclusion Our initial results indicate that placement of 125I seed strand and metallic stent combined with TACE is a safe and feasible therapeutic option for advanced HCC with malignant IVC obstruction.
10.A review of clinical characteristics and laboratory data of Alstr(o)m syndrome and two cases report
Jianhua LUO ; Ruiping YU ; Yan GU ; Bo LIU ; Yuanshuo FAN
Chinese Journal of Endocrinology and Metabolism 2011;27(11):897-900
Objective Alstr(o)m syndrome (AS) is a rare,autosomal recessive inherited disease characterized by various clinical manifestations.The aim of this study was to review the clinical characteristics and laboratory findings of AS.Methods Two cases of AS was reported.Combined with the clinical data of 7 cases of AS which had been reported in China,the clinical characteristics and laboratory findings of AS were reviewed.Results Visual disorder( median onset age:6.0 years ) and dysaudia( median onset age:10.3 years ) were found in 9 patients,short stature and obesity in 8 patients,acanthosis nigricans in 7 patients,diabetes mellitus( median onset age:14.5 years) in 6 patients,and heart disease in 4 patients; hyperuricemia was detected in 6 patients,hepatic dysfunction and hypertriglyceridemia in 5 patients.Conclusions Visual disorder was the first presentation in patients with AS.Deafness,obesity,diabetes,and short stature were common.These findings were helpful in making an early and accurate diagnosis and appropriate treatment.